美國Nanosphere, Inc www.nanosphere.us
Nanosphere公司位于伊力諾依州，生產(chǎn)能夠進行分子診斷測試的系統(tǒng)。今年早些時候，這套系統(tǒng)得以應(yīng)用來衡量病人血塊的凝結(jié)，以及一個病人如何通過新陳代謝；來應(yīng)對血塊的凝結(jié)。同時這家公司也在為癌癥、囊腫性纖維化基因突變、皰疹感染等疾病進行實驗。
美國Nanosphere
Nanosphere, Inc. is a nanotechnology-based healthcare company, offering proprietary breakthrough technologies that provide a unique and powerful solution to greatly simplify diagnostic testing. 
Nanosphere was founded in the year 2000 based upon nanotechnology discoveries at Northwestern University in Evanston, Illinois by Dr. Robert Letsinger and Dr. Chad Mirkin. Among other achievements, these discoveries made possible the consistent manufacturing and functionalization of gold nanoparticles with oligonucleotides (DNA or RNA), or antibodies that can be used in diagnostic applications to detect nucleic acid or protein targets, respectively.
Since its founding, Nanosphere has made continuous enhancements to the original technology advances by coupling the gold nanoparticle chemistry and capabilities with multiplex array analysis, microfluidics, and human factors instrument engineering and software development to produce a full-solution, diagnostics workstation, the Verigene® System.
The company is now a fully-integrated, healthcare company with established cGMP manufacturing operations, leading edge research and development teams, and veteran customer service and support teams.